Bisphosphonates vs placebo/observation
Overall survival postmenopausal women · women with early breast cancer
Bisphosphonates leads to lower overall survival postmenopausal women compared with placebo/observation (high certainty).
1 finding from 1 review
- HR 0.77 [0.66, 0.9]4 studies · 6048 participantsHigh